Search / Trial NCT06234709

Long-term Mortality After Intensive Care Considering Comorbidity and Admission Diagnoses

Launched by ANNA ARONSSON · Jan 22, 2024

Trial Information

Current as of October 08, 2024

Completed

Keywords

Comorbidity Intensive Care Saps3

Description

The study population included all patients \> 16 years old admitted to an ICU during the years 2006 to 2012 and registered in the Swedish Intensive Care Registry (SIR). Hospital discharge diagnoses from in-patient care five years preceding the index time for the ICU admission were extracted from the National Patient Register (NPR) and linked to ICU admissions using unique person identity numbers. Follow-up for all-cause mortality were extracted from the cause of death register at NPR.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The study population included all patients \> 16 years old admitted to an ICU during the years 2006 to 2012 and registered in the Swedish Intensive Care Registry (SIR)
  • Exclusion Criteria:
  • -

About Anna Aronsson

Anna Aronsson is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, Anna Aronsson collaborates with leading research institutions and healthcare professionals to design and execute robust clinical trials. The organization emphasizes rigorous adherence to regulatory standards and ethical practices, ensuring the safety and well-being of participants. By fostering a culture of collaboration and transparency, Anna Aronsson aims to drive breakthroughs in healthcare and contribute to the development of effective treatments across various medical fields.

Locations

Uppsala, , Sweden

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0